NMRA
Neumora Therapeutics Inc.

1,149
Mkt Cap
$419.39M
Volume
625,007.00
52W High
$3.65
52W Low
$0.611
PE Ratio
-1.72
NMRA Fundamentals
Price
$2.51
Prev Close
$2.57
Open
$2.55
50D MA
$2.69
Beta
1.82
Avg. Volume
1.7M
EPS (Annual)
-$1.53
P/B
3.08
Rev/Employee
$0.00
$1,382.46
Loading...
Loading...
News
all
press releases
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (Neumora or the Company) (NASDAQ...
Business Wire·2d ago
News Placeholder
More News
News Placeholder
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Short Interest Down 13.7% in February
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) saw a significant drop in short interest in the month of February. As of February 27th, there was short interest totaling 5,216,610 shares...
MarketBeat·4d ago
News Placeholder
Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 8.2% - What's Next?
Neumora Therapeutics (NASDAQ:NMRA) Trading Up 8.2% - Here's What Happened...
MarketBeat·11d ago
News Placeholder
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Hold" by Brokerages
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) has received an average recommendation of "Hold" from the eleven research firms that are presently covering the company, Marketbeat Ratings...
MarketBeat·19d ago
News Placeholder
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down - Time to Sell?
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down - Here's What Happened...
MarketBeat·19d ago
News Placeholder
GSA Capital Partners LLP Cuts Position in Neumora Therapeutics, Inc. $NMRA
GSA Capital Partners LLP lessened its position in Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 88.0% during the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·20d ago
News Placeholder
AlphaCore Capital LLC Has $1.16 Million Stock Holdings in Neumora Therapeutics, Inc. $NMRA
AlphaCore Capital LLC increased its stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 89.1% during the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·23d ago
News Placeholder
Neumora Therapeutics (NMRA) Projected to Post Earnings on Monday
Neumora Therapeutics (NASDAQ:NMRA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...
MarketBeat·27d ago
News Placeholder
Insider Selling: Neumora Therapeutics (NASDAQ:NMRA) President Sells 5,967 Shares of Stock
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) President Joshua Pinto sold 5,967 shares of Neumora Therapeutics stock in a transaction on Tuesday, February 17th. The shares were sold at...
MarketBeat·29d ago
News Placeholder
Neumora Therapeutics (NASDAQ:NMRA) Insider Paul Berns Sells 9,819 Shares
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) insider Paul Berns sold 9,819 shares of the firm's stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an...
MarketBeat·1mo ago
<
1
2
...
>

Latest NMRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.